Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AdaptHealth (AHCO) Invested Capital (2017 - 2026)

AdaptHealth has reported Invested Capital over the past 9 years, most recently at $1.6 billion for Q4 2025.

  • For Q4 2025, Invested Capital fell 55.84% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, down 55.84%, while the annual FY2025 figure was $1.6 billion, 55.84% down from the prior year.
  • Invested Capital for Q4 2025 was $1.6 billion at AdaptHealth, down from $3.4 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $4.4 billion in Q1 2023 and troughed at $1.5 billion in Q2 2024.
  • A 5-year average of $2.8 billion and a median of $2.2 billion in 2022 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: soared 2117.38% in 2021 and later tumbled 55.96% in 2025.
  • Year by year, Invested Capital stood at $4.3 billion in 2021, then increased by 1.77% to $4.3 billion in 2022, then dropped by 16.83% to $3.6 billion in 2023, then decreased by 1.72% to $3.6 billion in 2024, then crashed by 55.84% to $1.6 billion in 2025.
  • Business Quant data shows Invested Capital for AHCO at $1.6 billion in Q4 2025, $3.4 billion in Q3 2025, and $3.4 billion in Q2 2025.